These data were consistent with lower risk immunophenotypic markers in the severe pediatric PAD cohort, including higher absolute counts of CD3+ T-cells, CD4+ T-cells, CD19+ B-cells, and CD19+CD27+IgM-IgD- class-switched memory B-cells. This evidence concerns the gene CD19 and peripheral arterial disease.